MANNING ANTHONY M. (Chief Scientific Officer) sold 3.1% of their position (403.00 shares) of MOMENTA PHARMACEUTICALS INC on the open market
Open‑market sale worth $11.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/13/2020ACC: 0001179110-20-009025
Officer· Chief Scientific Officer
Since Oct 2018
-403.00
Net shares
Net seller
$11.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
403.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−40.00
Price / share
$29.34
Trade value
$1.17K
% of position
0.3%
8/13/2020
13.18K→13.14K
Common Stock
Direct
Shares
−363.00
Price / share
$29.31
Trade value
$10.64K
% of position
2.8%
8/13/2020
13.14K→12.78K
Total
Net shares
−403.00
Net value
-$11.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/13/2020 | S · Sale | −40.00 | $29.34 | $1.17K | 0.3% | 13.18K | 13.14K |
| Common Stock Direct | 8/13/2020 | S · Sale | −363.00 | $29.31 | $10.64K | 2.8% | 13.14K | 12.78K |
| Total | −403.00 | -$11.81K | ||||||
Derivative Transactions0
No derivative transactions reported